Clinical Trials Browser

Phase NA × Lung Neoplasms × Artificial Intelligence × Clear all

NCT07458425 2026-03-09

The SENTINL-1 Study: Evaluating Patient-Reported Outcomes of AI-Inferred Lung Cancer Risk

Phase NA Not yet recruiting

Lung Neoplasms